241 related articles for article (PubMed ID: 37024479)
1. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction.
Gong L; Luo J; Zhang Y; Yang Y; Li S; Fang X; Zhang B; Huang J; Chow LK; Chung D; Huang J; Huang C; Liu Q; Bai L; Tiu YC; Wu P; Wang Y; Tsao GS; Kwong DL; Lee AW; Dai W; Guan XY
Nat Commun; 2023 Apr; 14(1):1912. PubMed ID: 37024479
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Ujiie N; Kosaka A; Ohkuri T; Oikawa K; Sato R; Wakisaka R; Kono M; Yamaki H; Ohara K; Kumai T; Kishibe K; Katada A; Hayashi T; Kobayashi H
Cancer Sci; 2024 Apr; 115(4):1073-1084. PubMed ID: 38279834
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer.
Kong F; Ye Q; Xiong Y
Funct Integr Genomics; 2023 Jan; 23(1):48. PubMed ID: 36700974
[TBL] [Abstract][Full Text] [Related]
4. CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.
Arroyo Hornero R; Georgiadis C; Hua P; Trzupek D; He LZ; Qasim W; Todd JA; Ferreira RC; Wood KJ; Issa F; Hester J
Commun Biol; 2020 Jul; 3(1):375. PubMed ID: 32665635
[TBL] [Abstract][Full Text] [Related]
5. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.
Coquet JM; Ribot JC; Bąbała N; Middendorp S; van der Horst G; Xiao Y; Neves JF; Fonseca-Pereira D; Jacobs H; Pennington DJ; Silva-Santos B; Borst J
J Exp Med; 2013 Apr; 210(4):715-28. PubMed ID: 23547099
[TBL] [Abstract][Full Text] [Related]
6. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.
Ye C; Low BE; Wiles MV; Brusko TM; Serreze DV; Driver JP
J Immunol; 2020 Oct; 205(7):1763-1777. PubMed ID: 32868408
[TBL] [Abstract][Full Text] [Related]
7. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.
Izawa K; Martin E; Soudais C; Bruneau J; Boutboul D; Rodriguez R; Lenoir C; Hislop AD; Besson C; Touzot F; Picard C; Callebaut I; de Villartay JP; Moshous D; Fischer A; Latour S
J Exp Med; 2017 Jan; 214(1):73-89. PubMed ID: 28011863
[TBL] [Abstract][Full Text] [Related]
8. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
[TBL] [Abstract][Full Text] [Related]
9. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.
Abolhassani H; Edwards ES; Ikinciogullari A; Jing H; Borte S; Buggert M; Du L; Matsuda-Lennikov M; Romano R; Caridha R; Bade S; Zhang Y; Frederiksen J; Fang M; Bal SK; Haskologlu S; Dogu F; Tacyildiz N; Matthews HF; McElwee JJ; Gostick E; Price DA; Palendira U; Aghamohammadi A; Boisson B; Rezaei N; Karlsson AC; Lenardo MJ; Casanova JL; Hammarström L; Tangye SG; Su HC; Pan-Hammarström Q
J Exp Med; 2017 Jan; 214(1):91-106. PubMed ID: 28011864
[TBL] [Abstract][Full Text] [Related]
10. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.
Welten SP; Redeker A; Franken KL; Benedict CA; Yagita H; Wensveen FM; Borst J; Melief CJ; van Lier RA; van Gisbergen KP; Arens R
J Virol; 2013 Jun; 87(12):6851-65. PubMed ID: 23576505
[TBL] [Abstract][Full Text] [Related]
11. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
[TBL] [Abstract][Full Text] [Related]
12. Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma.
Benhamouda N; Sam I; Epaillard N; Gey A; Phan L; Pham HP; Gruel N; Saldmann A; Pineau J; Hasan M; Quiniou V; Nevoret C; Verkarre V; Libri V; Mella S; Granier C; Broudin C; Ravel P; De Guillebon E; Mauge L; Helley D; Jabla B; Chaput N; Albiges L; Katsahian S; Adam J; Mejean A; Adotevi O; Vano YA; Oudard S; Tartour E
Clin Cancer Res; 2022 Nov; 28(22):4983-4994. PubMed ID: 36067339
[TBL] [Abstract][Full Text] [Related]
13. The dual role of CD70 in B-cell lymphomagenesis.
Nie M; Ren W; Ye X; Berglund M; Wang X; Fjordén K; Du L; Giannoula Y; Lei D; Su W; Li W; Liu D; Linderoth J; Jiang C; Bao H; Jiang W; Huang H; Hou Y; Zhu S; Enblad G; Jerkeman M; Wu K; Zhang H; Amini RM; Li ZM; Pan-Hammarström Q
Clin Transl Med; 2022 Dec; 12(12):e1118. PubMed ID: 36471481
[TBL] [Abstract][Full Text] [Related]
14. Increased CD8
Zhao S; Zhang Y; Huang G; Luo W; Li Y; Xiao Y; Zhou M; Li Y; Lai J; Li Y; Li B
Blood Cells Mol Dis; 2019 Jul; 77():34-42. PubMed ID: 30953940
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicity.
Yamada S; Shinozaki K; Agematsu K
Clin Exp Immunol; 2002 Dec; 130(3):424-30. PubMed ID: 12452832
[TBL] [Abstract][Full Text] [Related]
16. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
[TBL] [Abstract][Full Text] [Related]
17. Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions.
Beishuizen CR; Kragten NA; Boon L; Nolte MA; van Lier RA; van Gisbergen KP
J Immunol; 2009 Nov; 183(10):6442-51. PubMed ID: 19864607
[TBL] [Abstract][Full Text] [Related]
18. CD70-mediated CD27 expression downregulation contributed to the regulatory B10 cell impairment in rheumatoid arthritis.
Shi L; Hu F; Zhu L; Xu C; Zhu H; Li Y; Liu H; Li C; Liu N; Xu L; Mu R; Li Z
Mol Immunol; 2020 Mar; 119():92-100. PubMed ID: 32006824
[TBL] [Abstract][Full Text] [Related]
19. T Cell-Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses.
O'Neill RE; Du W; Mohammadpour H; Alqassim E; Qiu J; Chen G; McCarthy PL; Lee KP; Cao X
J Immunol; 2017 Nov; 199(10):3700-3710. PubMed ID: 29046346
[TBL] [Abstract][Full Text] [Related]
20. ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.
Silence K; Dreier T; Moshir M; Ulrichts P; Gabriels SM; Saunders M; Wajant H; Brouckaert P; Huyghe L; Van Hauwermeiren T; Thibault A; De Haard HJ
MAbs; 2014; 6(2):523-32. PubMed ID: 24492296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
